Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

AbbVie Inc (NYSE:ABBV)

61.66
Delayed Data
As of 4:01pm ET
 -0.20 / -0.32%
Today’s Change
51.60
Today|||52-Week Range
68.12
-1.53%
Year-to-Date
Allergan's Uterine Fibroids Candidate Positive in Phase III
5:22pm / Zacks.com - Paid Partner Content
Biotech Just Got Trumped
Jan 12 / TheStreet.com - Paid Partner Content
5 Most Important Drugs to Johnson & Johnson in 2017
5:14pm / MotleyFool.com - Paid Partner Content
Trump Attacks Biotech & Pharma: ETFs Bleed
Jan 12 / Zacks.com - Paid Partner Content
What???s Ahead for Johnson & Johnson (JNJ) in Q4 Earnings?
9:30am / Zacks.com - Paid Partner Content
7 Reasons AbbVie's Stock Could Soar in 2017
Jan 12 / MotleyFool.com - Paid Partner Content
Biotech Sector to See M&A, Earnings Action
Jan 17 / TheStreet.com - Paid Partner Content
First Dallas Securities Inc. Buys Mylan NV, Forterra Inc, American Express Co, Sells ...
Jan 11 / GuruFocus News - Paid Partner Content
Coherus Offers Positive Phase III Data on Humira Biosimilar
Jan 13 / Zacks.com - Paid Partner Content
Entana Pharmaceuticals Releases Study Results of Hepatitis Treatment in Japanese Pati...
Jan 11 / GuruFocus News - Paid Partner Content

Today’s Trading

Previous close61.86
Today’s open61.83
Day’s range61.32 - 62.14
Volume5,519,407
Average volume (3 months)7,491,897
Market cap$100.5B
Dividend yield4.15%
Data as of 4:01pm ET, 01/18/2017

Growth & Valuation

Earnings growth (last year)+184.55%
Earnings growth (this year)+12.41%
Earnings growth (next 5 years)+15.81%
Revenue growth (last year)+14.52%
P/E ratio16.7
Price/Sales4.24
Price/Book25.24

Competitors

 Today’s
change
Today’s
% change
GSKGlaxoSmithKline-0.41-1.04%
SNYSanofi-0.20-0.49%
BMYBristol-Myers Squibb-0.21-0.37%
CELGCelgene+0.27+0.23%
Data as of 4:02pm ET, 01/18/2017

Financials

Next reporting dateJanuary 27, 2017
EPS forecast (this quarter)$1.19
Annual revenue (last year)$22.9B
Annual profit (last year)$5.1B
Net profit margin22.39%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman &
Chief Executive Officer
Richard A. Gonzalez
Senior Vice President-
Operations
Azita Saleki-Gerhardt
Corporate headquarters
North Chicago, Illinois

Forecasts


Search for Jobs